Mereo BioPharma Group

$3.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
+$0.02 (+0.57%) As of 10:26 PM UTC after-hours

Why Robinhood?

You can buy or sell MREO and other stocks, options, and ETFs commission-free!

About MREO

Mereo BioPharma Group plc American Depositary Shares, also called Mereo BioPharma Group, is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO
Denise Vera Scots-Knight
Employees
38
Headquarters
London, Greater London
Founded
2015
Market Cap
371.56M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.88M
High Today
$3.58
Low Today
$3.40
Open Price
$3.52
Volume
1.40M
52 Week High
$4.71
52 Week Low
$1.03

MREO Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 31, After Hours

You May Also Like

SCHR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure